Saran Kumar
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Aging top 5%
Papers in
-
- Advancements in Transdermal Drug Delivery 7
- Advanced Drug Delivery Systems 4
-
- Protease and Inhibitor Mechanisms 3
- Co-authors
- Ruowen Ge (4 shared papers)A. Waseem Malick (10 shared papers)Eli Keshet (7 shared papers)Myriam Grunewald (6 shared papers)Maxim Mogilevsky (4 shared papers)Rotem Karni (3 shared papers)Alberto Gabizón (3 shared papers)Hilary Shmeeda (3 shared papers)
- Journals
- Journal of Controlled Release (5 papers)Journal of Pharmaceutical Sciences (4 papers)Scientific Reports (2 papers)Cell Metabolism (2 papers)Pharmaceutical Research (2 papers)
- Partner nations
- IndiaIsraelUnited States
In The Last Decade
Saran Kumar
42 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 101
- Pharmaceutical Science 217
- Aging 42
- Cancer Research 237
- Biomaterials 130
- Drug Discovery 2
Countries citing papers authored by Saran Kumar
This map shows the geographic impact of Saran Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saran Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saran Kumar more than expected).
Fields of papers citing papers by Saran Kumar
This network shows the impact of papers produced by Saran Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saran Kumar. The network helps show where Saran Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Saran Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 267 | |
| 2 | 2018 | 156 | |
| 3 | 2019 | 94 | |
| 4 | 2019 | 85 | |
| 5 | 2010 | 83 | |
| 6 | 1993 | 76 | |
| 7 | 2012 | 67 | |
| 8 | 2012 | 64 | |
| 9 | 2018 | 62 | |
| 10 | 2018 | 52 | |
| 11 | 2016 | 51 | |
| 12 | 2016 | 49 | |
| 13 | 2017 | 46 | |
| 14 | 2020 | 39 | |
| 15 | 2018 | 38 | |
| 16 | 2013 | 36 | |
| 17 | 1992 | 32 | |
| 18 | 1992 | 32 | |
| 19 | 1989 | 31 | |
| 20 | 1992 | 26 |
About Saran Kumar
Saran Kumar is a scholar working on Pharmaceutical Science, Cancer Research, Biomaterials, Molecular Biology and Oncology, having authored 48 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Cancer Cells and Metastasis (5 papers), Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Protease and Inhibitor Mechanisms (3 papers), Glioma Diagnosis and Treatment (3 papers) and DNA and Nucleic Acid Chemistry (2 papers). The work is most often cited by research in Pharmaceutical Science (217 citations), Aging (42 citations), Cancer Research (237 citations), Biomaterials (130 citations) and Drug Discovery (2 citations). Saran Kumar has collaborated with scholars based in India, Israel and United States. Frequent co-authors include Ruowen Ge, A. Waseem Malick, Eli Keshet, Myriam Grunewald, Maxim Mogilevsky, Rotem Karni, Alberto Gabizón, Hilary Shmeeda, Yasmine Amitay and Soheila Sharghi-Namini. Their work appears in journals such as Journal of Controlled Release, Journal of Pharmaceutical Sciences, Scientific Reports, Cell Metabolism and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.